Hannah Chustz, OD
Optometrist · Baton Rouge, LANPI 1770210114
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,194 of the $5,820 with a category attached, or 89.3%. It is spread thinly across 15 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,863, more than ten times the $139 reported in 2022. Among optometrist clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $47.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Johnson & Johnson Vision Care, Inc.$1K
- Glaukos Corporation$828
- Bausch & Lomb Americas Inc.$793
- Biotissue Holdings Inc.$327
- Tarsus Pharmaceuticals, Inc.$230
- plus $1K from 9 others
What the payments were for
- Travel & lodging$61811%
- Food & beverage$5,19489%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 32 | $1,296 |
| Johnson & Johnson Vision Care, Inc. | 16 | $1,155 |
| Glaukos Corporation | 9 | $828 |
| Bausch & Lomb Americas Inc. | 25 | $793 |
| Biotissue Holdings Inc. | 8 | $327 |
| Tarsus Pharmaceuticals, Inc. | 6 | $230 |
| Harrow Eye, LLC | 3 | $182 |
| Dompe US, Inc. | 3 | $181 |
| Sun Pharmaceutical Industries Inc. | 7 | $174 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $138 |
| Mallinckrodt Hospital Products Inc. | 2 | $138 |
| AbbVie | 5 | $137 |
| Oyster Point Pharma, Inc. | 3 | $131 |
| Ocular Therapeutix, Inc. | 1 | $100 |
| Rxsight Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$768
- iDoseTR$235
- INFUSE$223
- Photrexa Viscous and Photrexa$177
- Tecnis IOL$138
- Prokera$127
- VEVYE$124
- XDEMVY$123
- TRYPTYR$122
- ACTHAR$117
- Oxervate$117
- BIOTRUE ONE DAY$117
- DAILIES TOTAL1$115
- Precision7$106
- INFUSE MULTIFOCAL$101
- Precision 1$101
- DEXTENZA$100
- TYRVAYA$100
How this compares
$5,820 in reported general payments places this provider in the 90th percentile of 500 optometrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 11 | $6,446 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 23 | $2,800 |
| Prednisolone Acetate | 38 | $1,181 |
| Latanoprost | 95 | $1,086 |
| Azelastine Hcl | 33 | $1,051 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 68 | $944 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 19 | $923 |
| MoxifloxacinMoxifloxacin Hcl | 23 | $553 |
| ErythromycinErythromycin Base | 32 | $375 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $204 |
| Timolol Maleate | 16 | $172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $137 | $6,44611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 500 optometrist providers in Louisiana.
Other optometrist in Baton Rouge
- Eric ThaiBaton Rouge$7K
- Kevin DuongBaton Rouge$7K
- Khanh TrinhBaton Rouge$7K
- Christine NorredBaton Rouge$6K
- Shonda AchordBaton Rouge$6K
- Pamela TheriotShreveport$207K
- Joshua DavidsonGonzales$189K
- Jeffrey WilhiteMarrero$86K
- Christopher WrotenHammond$59K
- James LamarNew Orleans$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.